Does NIRAPARIB Cause Gastrointestinal motility disorder? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Gastrointestinal motility disorder have been filed in association with NIRAPARIB (ZEJULA). This represents 0.2% of all adverse event reports for NIRAPARIB.
52
Reports of Gastrointestinal motility disorder with NIRAPARIB
0.2%
of all NIRAPARIB reports
1
Deaths
14
Hospitalizations
How Dangerous Is Gastrointestinal motility disorder From NIRAPARIB?
Of the 52 reports, 1 (1.9%) resulted in death, 14 (26.9%) required hospitalization, and 2 (3.8%) were considered life-threatening.
Is Gastrointestinal motility disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does NIRAPARIB Cause?
Nausea (5,794)
Fatigue (5,240)
Constipation (4,128)
Platelet count decreased (4,102)
Insomnia (2,861)
Blood pressure increased (2,464)
Headache (2,383)
Off label use (2,213)
Vomiting (2,029)
Carbohydrate antigen 125 increased (1,868)
What Other Drugs Cause Gastrointestinal motility disorder?
ADALIMUMAB (207)
LEVOTHYROXINE (191)
LENALIDOMIDE (188)
POLYETHYLENE GLYCOL 3350 (163)
LINACLOTIDE (130)
CABOZANTINIB S-MALATE (98)
VEDOLIZUMAB (78)
CARBIDOPA\LEVODOPA (70)
SERTRALINE (65)
INFLIXIMAB (61)
Which NIRAPARIB Alternatives Have Lower Gastrointestinal motility disorder Risk?
NIRAPARIB vs NIRMATRELVIR\RITONAVIR
NIRAPARIB vs NIROGACESTAT
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE
NIRAPARIB vs NIRSEVIMAB
NIRAPARIB vs NIRSEVIMAB-ALIP